Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Munoz

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of Cell Biology|November 5, 2016
Kinesin-1 controls mast cell degranulation and anaphylaxis through PI3K-dependent recruitment to the granular Slp3/Rab27b complexIsabelle Munoz, Luca Danelli, Julien Claver, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 10, 2018
Kinesin-1 Is a New Actor Involved in Platelet Secretion and Thrombus StabilityFrédéric Adam, Alexandre Kauskot, Mathieu Kurowska, et al.
Frontiers in Pharmacology|July 18, 2024
Pharmacologic inhibition of dipeptidyl peptidase 1 (cathepsin C) does not block <i>in vitro</i> granzyme-mediated target cell killing by CD8 T or NK cellsVivien R Sutton, Sally V Watt, Hedieh Akhlaghi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2026
CDK4/6 Inhibition Enhances CAR-T Cell Therapy in Solid TumorsEmily J Lelliott, Jonathan Naddaf, Kun-Hui Lu, et al.
Nature Communications|February 17, 2026
High efficiency CRISPR knock-in demonstrates that TCF1 is insufficient to reverse T cell exhaustionMaria N de Menezes, Amanda X Y Chen, Nihali Kulkarni, et al.
Haematologica|November 26, 2020
The epigenetic regulator RINF (CXXC5) maintains <i>SMAD7</i> expression in human immature erythroid cells and sustains red blood cells expansionAudrey Astori, Gabriel Matherat, Isabelle Munoz, et al.
Nature Communications|November 2, 2023
A<sub>2A</sub>R eGFP reporter mouse enables elucidation of A<sub>2A</sub>R expression dynamics during anti-tumor immune responsesKirsten L Todd, Junyun Lai, Kevin Sek, et al.
Cell Reports|August 22, 2023
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunityImran G House, Emily B Derrick, Kevin Sek, et al.
Nature Immunology|February 10, 2026
Flt3L-mediated tumor cDC1 expansion enhances immunotherapy by priming stem-like CD8<sup>+</sup> T cells in lymph nodesJunyun Lai, Cheok Weng Chan, Jesse D Armitage, et al.
Nature Communications|July 3, 2025
Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumorsKevin Sek, Amanda X Y Chen, Thomas Cole, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Cell Biology|November 5, 2016
Kinesin-1 controls mast cell degranulation and anaphylaxis through PI3K-dependent recruitment to the granular Slp3/Rab27b complexIsabelle Munoz, Luca Danelli, Julien Claver, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 10, 2018
Kinesin-1 Is a New Actor Involved in Platelet Secretion and Thrombus StabilityFrédéric Adam, Alexandre Kauskot, Mathieu Kurowska, et al.
Frontiers in Pharmacology|July 18, 2024
Pharmacologic inhibition of dipeptidyl peptidase 1 (cathepsin C) does not block <i>in vitro</i> granzyme-mediated target cell killing by CD8 T or NK cellsVivien R Sutton, Sally V Watt, Hedieh Akhlaghi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2026
CDK4/6 Inhibition Enhances CAR-T Cell Therapy in Solid TumorsEmily J Lelliott, Jonathan Naddaf, Kun-Hui Lu, et al.
Nature Communications|February 17, 2026
High efficiency CRISPR knock-in demonstrates that TCF1 is insufficient to reverse T cell exhaustionMaria N de Menezes, Amanda X Y Chen, Nihali Kulkarni, et al.
Haematologica|November 26, 2020
The epigenetic regulator RINF (CXXC5) maintains <i>SMAD7</i> expression in human immature erythroid cells and sustains red blood cells expansionAudrey Astori, Gabriel Matherat, Isabelle Munoz, et al.
Nature Communications|November 2, 2023
A<sub>2A</sub>R eGFP reporter mouse enables elucidation of A<sub>2A</sub>R expression dynamics during anti-tumor immune responsesKirsten L Todd, Junyun Lai, Kevin Sek, et al.
Cell Reports|August 22, 2023
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunityImran G House, Emily B Derrick, Kevin Sek, et al.
Nature Immunology|February 10, 2026
Flt3L-mediated tumor cDC1 expansion enhances immunotherapy by priming stem-like CD8<sup>+</sup> T cells in lymph nodesJunyun Lai, Cheok Weng Chan, Jesse D Armitage, et al.
Nature Communications|July 3, 2025
Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumorsKevin Sek, Amanda X Y Chen, Thomas Cole, et al.
Pageof 2